Cargando…

Breast cancer recurrence after reconstruction: know thine enemy

Breast reconstruction proceeding cancer treatment carries risk, regardless of the type of surgery. From fat grafting, to flap placement, to implants, there is no guarantee that reconstruction will not stimulate breast cancer recurrence. Research in this field is clearly divided into two parts: scien...

Descripción completa

Detalles Bibliográficos
Autores principales: Brett, Elizabeth A., Aitzetmüller, Matthias M., Sauter, Matthias A., Huemer, Georg M., Machens, Hans-Günther, Duscher, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021250/
https://www.ncbi.nlm.nih.gov/pubmed/29963246
http://dx.doi.org/10.18632/oncotarget.25602
_version_ 1783335432648392704
author Brett, Elizabeth A.
Aitzetmüller, Matthias M.
Sauter, Matthias A.
Huemer, Georg M.
Machens, Hans-Günther
Duscher, Dominik
author_facet Brett, Elizabeth A.
Aitzetmüller, Matthias M.
Sauter, Matthias A.
Huemer, Georg M.
Machens, Hans-Günther
Duscher, Dominik
author_sort Brett, Elizabeth A.
collection PubMed
description Breast reconstruction proceeding cancer treatment carries risk, regardless of the type of surgery. From fat grafting, to flap placement, to implants, there is no guarantee that reconstruction will not stimulate breast cancer recurrence. Research in this field is clearly divided into two parts: scientific interventional studies and clinical retrospective evidence. The reconstructive procedure offers hypoxia, a wound microenvironment, bacterial load, adipose derived stem cells; agents shown experimentally to cause increased cancer cell activity. This is compelling scientific evidence which serves to bring uncertainty and fear to the reconstructive procedure. In the absence of clinical evidence, this laboratory literature landscape is now informing surgical choices. Curiously, clinical studies have not shown a clear link between breast cancer recurrence and reconstructive surgery. Where does that leave us? This review aims to analyze the science and the surgery, thereby understanding the oncological fear which accompanies breast cancer reconstruction.
format Online
Article
Text
id pubmed-6021250
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-60212502018-06-29 Breast cancer recurrence after reconstruction: know thine enemy Brett, Elizabeth A. Aitzetmüller, Matthias M. Sauter, Matthias A. Huemer, Georg M. Machens, Hans-Günther Duscher, Dominik Oncotarget Review Breast reconstruction proceeding cancer treatment carries risk, regardless of the type of surgery. From fat grafting, to flap placement, to implants, there is no guarantee that reconstruction will not stimulate breast cancer recurrence. Research in this field is clearly divided into two parts: scientific interventional studies and clinical retrospective evidence. The reconstructive procedure offers hypoxia, a wound microenvironment, bacterial load, adipose derived stem cells; agents shown experimentally to cause increased cancer cell activity. This is compelling scientific evidence which serves to bring uncertainty and fear to the reconstructive procedure. In the absence of clinical evidence, this laboratory literature landscape is now informing surgical choices. Curiously, clinical studies have not shown a clear link between breast cancer recurrence and reconstructive surgery. Where does that leave us? This review aims to analyze the science and the surgery, thereby understanding the oncological fear which accompanies breast cancer reconstruction. Impact Journals LLC 2018-06-12 /pmc/articles/PMC6021250/ /pubmed/29963246 http://dx.doi.org/10.18632/oncotarget.25602 Text en Copyright: © 2018 Brett et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Brett, Elizabeth A.
Aitzetmüller, Matthias M.
Sauter, Matthias A.
Huemer, Georg M.
Machens, Hans-Günther
Duscher, Dominik
Breast cancer recurrence after reconstruction: know thine enemy
title Breast cancer recurrence after reconstruction: know thine enemy
title_full Breast cancer recurrence after reconstruction: know thine enemy
title_fullStr Breast cancer recurrence after reconstruction: know thine enemy
title_full_unstemmed Breast cancer recurrence after reconstruction: know thine enemy
title_short Breast cancer recurrence after reconstruction: know thine enemy
title_sort breast cancer recurrence after reconstruction: know thine enemy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021250/
https://www.ncbi.nlm.nih.gov/pubmed/29963246
http://dx.doi.org/10.18632/oncotarget.25602
work_keys_str_mv AT brettelizabetha breastcancerrecurrenceafterreconstructionknowthineenemy
AT aitzetmullermatthiasm breastcancerrecurrenceafterreconstructionknowthineenemy
AT sautermatthiasa breastcancerrecurrenceafterreconstructionknowthineenemy
AT huemergeorgm breastcancerrecurrenceafterreconstructionknowthineenemy
AT machenshansgunther breastcancerrecurrenceafterreconstructionknowthineenemy
AT duscherdominik breastcancerrecurrenceafterreconstructionknowthineenemy